FOCUS Investment Banking Named #1 Lower Middle Market M&A Advisor In Q2 2023​

2024-03-19T15:33:27+00:00Advanced Manufacturing, Agriculture, Auto parts and accessories, Automotive Aftermarket, Automotive Dealers, Behavioral Health, Biotech, Blogs, Car Washes, Cardiology, Cloud Services, Collision, Construction, Consumer, Dermatology, Distribution, Downloads, E-commerce, E-Learning, Education & Human Capital Development News, Electronics, Engineering, ENT & Allergy, Entertainment, Environmental Services, Federal Contracting, Financial Services, FOCUS Sale Preparation, Food & Beverage, Gastroenterology, Government and Defense, Healthcare, Home Health & Hospice, Human Capital Management, Industrials and Energy, Managed Service Providers, Mergers & Acquisitions News, Mergers, Acquisitions & Divestitures, Oil and Lube, Paint Jobbers, Supply Chain, Technology Services, Telecom Technologies & Services, Tire and Service|

Washington, DC, (July 27, 2023) – FOCUS Investment Banking (“FOCUS”) ...

ENT & Allergy – Q3 2021 Acquisition Activity and Outlook

2024-02-12T22:57:14+00:00ENT & Allergy, Healthcare|

After a Quiet Quarter for ENT & Allergy Practice Acquisitions, We See Increasing Opportunity in Q4

The third quarter of 2021 delivered one major reported ENT practice acquisition, still far below the peak of activity in Q1. In September, an investment from The Beekman Group formed a partnership with Allergy & ENT Associates, a management services organization that supports a network of sixteen ENT clinics in the Greater Houston area.

ENT & Allergy Report – Q1 2021 Acquisition Activity and Outlook

2024-02-12T22:57:15+00:00ENT & Allergy, Healthcare|

Private Equity Interest in ENT & Allergy Practices Accelerates. Expect Increasing Opportunity for Large Practice Sellers.

The first quarter of 2021 delivered five reported ENT practice acquisitions marking the most active three-month M&A period we have seen in the specialty. Notably, Audax Private Equity formally named its portfolio company “Elevate ENT” and expanded into Texas with the major acquisition of Texas ENT Specialists. While the next quarter may not produce as many deals, activity should remain high throughout this year.
Go to Top